Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Signal Transduct Target Ther ; 9(1): 209, 2024 Aug 14.
Artigo em Inglês | MEDLINE | ID: mdl-39138145

RESUMO

Non-genetic mechanisms have recently emerged as important drivers of anticancer drug resistance. Among these, the drug tolerant persister (DTP) cell phenotype is attracting more and more attention and giving a predominant non-genetic role in cancer therapy resistance. The DTP phenotype is characterized by a quiescent or slow-cell-cycle reversible state of the cancer cell subpopulation and inert specialization to stimuli, which tolerates anticancer drug exposure to some extent through the interaction of multiple underlying mechanisms and recovering growth and proliferation after drug withdrawal, ultimately leading to treatment resistance and cancer recurrence. Therefore, targeting DTP cells is anticipated to provide new treatment opportunities for cancer patients, although our current knowledge of these DTP cells in treatment resistance remains limited. In this review, we provide a comprehensive overview of the formation characteristics and underlying drug tolerant mechanisms of DTP cells, investigate the potential drugs for DTP (including preclinical drugs, novel use for old drugs, and natural products) based on different medicine models, and discuss the necessity and feasibility of anti-DTP therapy, related application forms, and future issues that will need to be addressed to advance this emerging field towards clinical applications. Nonetheless, understanding the novel functions of DTP cells may enable us to develop new more effective anticancer therapy and improve clinical outcomes for cancer patients.


Assuntos
Antineoplásicos , Plasticidade Celular , Resistencia a Medicamentos Antineoplásicos , Neoplasias , Humanos , Neoplasias/tratamento farmacológico , Neoplasias/genética , Neoplasias/patologia , Resistencia a Medicamentos Antineoplásicos/genética , Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , Antineoplásicos/farmacologia , Antineoplásicos/uso terapêutico , Plasticidade Celular/efeitos dos fármacos , Plasticidade Celular/genética
2.
Front Biosci (Landmark Ed) ; 27(9): 263, 2022 09 16.
Artigo em Inglês | MEDLINE | ID: mdl-36224007

RESUMO

Cancer progression and metastases are the leading causes of poor outcomes in patients with colon cancer. Colon cancer metastasis is a multigene, multistep, multistage complex process in which target genes, microRNAs, epithelial-stromal transformation, tumour stem cells, the tumour microenvironment, and various cell signalling pathways are implicated in the progression and metastasis of colon cancer. Although conventional therapies have made significant advances in treating the progression and metastasis of colorectal cancer, they have failed to improve survival outcomes. Natural compounds may have more significant potential in preventing and treating colon cancer. Active natural compounds exert their antitumor effects by inducing tumour cell differentiation, promoting tumour cell apoptosis, inhibiting tumour vascular growth, and regulating immunity. Natural compounds, combined with conventional therapies, can target mutant genes and various cellular signalling pathways, inhibit epithelial-stromal transformation, and improve the tumour microenvironment to inhibit tumour progression and metastasis. The synergism of natural compounds and conventional therapeutics has the potential to become a promising therapy for treating colorectal cancer progression and metastases.


Assuntos
Neoplasias do Colo , Neoplasias Colorretais , MicroRNAs , Apoptose , Neoplasias do Colo/metabolismo , Neoplasias Colorretais/tratamento farmacológico , Neoplasias Colorretais/genética , Neoplasias Colorretais/patologia , Humanos , Metástase Neoplásica , Células-Tronco Neoplásicas/patologia , Microambiente Tumoral
3.
Front Pharmacol ; 13: 919819, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36046825

RESUMO

Macropinocytosis, a unique endocytosis pathway characterized by nonspecific internalization, has a vital role in the uptake of extracellular substances and antigen presentation. It is known to have dual effects on cancer cells, depending on cancer type and certain microenvironmental conditions. It helps cancer cells survive in nutrient-deficient environments, enhances resistance to anticancer drugs, and promotes invasion and metastasis. Conversely, overexpression of the RAS gene alongside drug treatment can lead to methuosis, a novel mode of cell death. The survival and proliferation of cancer cells is closely related to macropinocytosis in the tumor microenvironment (TME), but identifying how these cells interface with the TME is crucial for creating drugs that can limit cancer progression and metastasis. Substantial progress has been made in recent years on designing anticancer therapies that utilize the effects of macropinocytosis. Both the induction and inhibition of macropinocytosis are useful strategies for combating cancer cells. This article systematically reviews the general mechanisms of macropinocytosis, its specific functions in tumor cells, its occurrence in nontumor cells in the TME, and its application in tumor therapies. The aim is to elucidate the role and therapeutic potential of macropinocytosis in cancer treatment.

4.
Technol Cancer Res Treat ; 21: 15330338221100355, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35903930

RESUMO

The most efficient way to treat tumors is through surgery. However, many cancer patients have a poor prognosis even when they undergo radical excision at an early stage. Micrometastasis is one of the most critical factors that induced this situation. Undetected micrometastasis can lead to the failure of initial treatment. Therefore, preoperative and intraoperative detection of micrometastasis could have a significant clinical influence on the prognosis and optimal therapy for cancer patients. Additionally, to achieve this goal, researchers have aimed to create more effective detection technologies. Herein, we classify the currently reported micrometastasis detection technologies, introduce some representative samples for each technology, including the limitations, and provide future directions to overcome the limitations.


Assuntos
Linfonodos , Micrometástase de Neoplasia , Humanos , Linfonodos/patologia , Metástase Linfática/patologia , Micrometástase de Neoplasia/diagnóstico , Micrometástase de Neoplasia/patologia , Estadiamento de Neoplasias , Prognóstico
5.
Appl Biochem Biotechnol ; 168(1): 37-46, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21603951

RESUMO

Physicochemical characteristics of wood powder acid hydrolysis residue (WAHR) were studied firstly in this study, and WAHL (lignin derived from WAHR) was separated successfully from WAHR based on an improved isolating method. The content of functional group such as phenolic hydroxyl group of guaiacyl, syringyl, and hydroxyl-phenyl units in WAHL were identified by (31)P-NMR and DFRC (derivatization followed by reductive cleavage) method. Thermal degradation experiments were carried out on a thermogravimetric (TG) analyzer to show pyrolysis characteristics of WAHL. The compositions of pyrolysis products of WAHL were also studied throughout a pyrolysis-gas chromatography-mass spectrometry (Py-GC-MS) analyzer. It was shown that the pyrolysis of WAHL took place in a wide temperature range and there were two obvious peaks in the differential thermogravimetric diagram. Results of Py-GC-MS analysis indicated that pyrolysis products were mainly formed through cleavage of the ß-O-4 connection and multiple pyrolysis.


Assuntos
Biotecnologia/métodos , Lignina/química , Temperatura , Madeira/química , Ácidos/química , Cromatografia em Gel , Análise Diferencial Térmica , Éter/química , Cromatografia Gasosa-Espectrometria de Massas , Hidrólise , Peso Molecular , Fenóis/química , Pós , Espectroscopia de Infravermelho com Transformada de Fourier , Termogravimetria
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA